Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

Synonyms: null

Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.

Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 6.1mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective Integrin Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.

Product Details

CAS No. 211323-03-4
Molecular Weight 146.66
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) supplier | purchase Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) cost | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) manufacturer | order Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) | Erlizumab (Anti-Integrin b2 / ITGB2 / CD18) distributor